FDA Inspection
Medion Grifols Diagnostics AGMedion Grifols Diagnostics AG – FDA Inspection, Dec 7, 2018
Record Details
This FDA Inspection record concerns Medion Grifols Diagnostics AG, with an inspection on December 7, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · c1a312d3-dbe2-4d10-b49b-1753ce70ee25
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1073705
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 820.80(a)Lack of or inadequate procedures - Acceptance activities
- 21 CFR 820.100(a)Lack of or inadequate procedures
- 21 CFR 820.30(g)Design Validation - Risk analysis not performed/inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Medion Grifols Diagnostics AG
7| Date | Classification | Office | Project area |
|---|---|---|---|
| April 30, 2024 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 2, 2017 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 30, 2015 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
| March 7, 2013 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 11, 2011 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
Other documents for Medion Grifols Diagnostics AG
- FDA Inspection 1237209 - 2024-04-30
- FDA Inspection 1012899 - 2017-03-02
- FDA Inspection 938807 - 2015-07-30
- FDA Inspection 827695 - 2013-03-07
- FDA Inspection 741885 - 2011-08-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.